These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1797049)

  • 1. The cell mediated and humoral immune response to vaccination with acellular and whole cell pertussis vaccine in adult humans.
    Petersen JW; Ibsen PH; Bentzon MW; Capiau C; Heron I
    FEMS Microbiol Immunol; 1991 Oct; 3(5):279-87. PubMed ID: 1797049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific immune response in adult medical personnel immunized with acellular pertussis vaccine with special emphasis on T helper cell response.
    Lin TY; Chiang BL
    Vaccine; 1997 Dec; 15(17-18):1917-21. PubMed ID: 9413102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restricted antibody response to Bordetella pertussis filamentous hemagglutinin induced by whole-cell and acellular pertussis vaccines.
    Asgarian-Omran H; Golara M; Abdolmaleki S; Navabi SS; Alipour H; Khoshnoodi J; Hemmati A; Zarei S; Jeddi-Tehrani M; Shokri F
    Infect Dis (Lond); 2016 Feb; 48(2):127-32. PubMed ID: 26439274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa.
    Podda A; Nencioni L; Marsili I; Peppoloni S; Volpini G; Donati D; Di Tommaso A; De Magistris MT; Rappuoli R
    Vaccine; 1991 Oct; 9(10):741-5. PubMed ID: 1759492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens.
    Ausiello CM; Lande R; la Sala A; Urbani F; Cassone A
    J Infect Dis; 1998 Aug; 178(2):466-70. PubMed ID: 9697728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does whole-cell pertussis vaccine protect black South African infants? Assessment of post-vaccination events and antibody responses to pertussis toxin, filamentous haemagglutinin and agglutinogens 2 and 3.
    Ramkissoon A; Coovadia HM; Loening WE; Ndlovana M
    S Afr Med J; 1991 Jun; 79(11):645-9. PubMed ID: 1675492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of human T-cell epitopes on the S4 subunit of pertussis toxin.
    Petersen JW; Holm A; Ibsen PH; Hasløv K; Capiau C; Heron I
    Infect Immun; 1992 Oct; 60(10):3962-70. PubMed ID: 1383145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro induction of antigen specific antibody synthesis and proliferation of T lymphocytes with acellular pertussis vaccines, pertussis toxin and filamentous haemagglutinin in humans.
    Wiertz EJ; Loggen HG; Walvoort HC; Kreeftenberg JG
    J Biol Stand; 1989 Apr; 17(2):181-90. PubMed ID: 2785517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
    Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
    Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
    Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses to pertussis antigens eight years after booster immunization with acellular vaccines in adults.
    Tran Minh NN; He Q; Edelman K; Putto-Laurila A; Arvilommi H; Viljanen MK; Mertsola J
    Vaccine; 2000 Apr; 18(19):1971-4. PubMed ID: 10706957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunity after pertussis vaccination and after natural infection.
    Zepp F; Knuf M; Habermehl P; Schmitt HJ; Meyer C; Clemens R; Slaoui M
    Dev Biol Stand; 1997; 89():307-14. PubMed ID: 9272364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine.
    Petersen JW; Andersen P; Ibsen PH; Capiau C; Wachmann CH; Hasløv K; Heron I
    Vaccine; 1993; 11(4):463-72. PubMed ID: 8470432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination.
    Rieber N; Graf A; Belohradsky BH; Hartl D; Urschel S; Riffelmann M; Wirsing von König CH; Liese J
    Vaccine; 2008 Dec; 26(52):6929-35. PubMed ID: 18852002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term immunogenicity of a single dose of acellular pertussis vaccine in paediatric health-care workers.
    Littmann M; Hülsse C; Riffelmann M; Wirsing von König CH
    Vaccine; 2008 May; 26(19):2344-9. PubMed ID: 18396360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults.
    Di Tommaso A; Bartalini M; Peppoloni S; Podda A; Rappuoli R; De Magistris MT
    Vaccine; 1997 Aug; 15(11):1218-24. PubMed ID: 9286047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens.
    Berbers GA; van de Wetering MS; van Gageldonk PG; Schellekens JF; Versteegh FG; Teunis PF
    Vaccine; 2013 Aug; 31(36):3732-8. PubMed ID: 23742995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines.
    Barkoff AM; Guiso N; Guillot S; Xing D; Markey K; Berbers G; Mertsola J; He Q
    J Immunol Methods; 2014 Jun; 408():142-8. PubMed ID: 24925807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R; Lønnes T; Møgster B; Berdal BP
    Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cellular immune response to Bordetella pertussis in two children with whooping cough.
    Hafler JP; Pohl-Koppe A
    Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.